HRP20160978T1 - Pripravak za liječenje neplodnosti - Google Patents
Pripravak za liječenje neplodnosti Download PDFInfo
- Publication number
- HRP20160978T1 HRP20160978T1 HRP20160978TT HRP20160978T HRP20160978T1 HR P20160978 T1 HRP20160978 T1 HR P20160978T1 HR P20160978T T HRP20160978T T HR P20160978TT HR P20160978 T HRP20160978 T HR P20160978T HR P20160978 T1 HRP20160978 T1 HR P20160978T1
- Authority
- HR
- Croatia
- Prior art keywords
- preparation
- alpha lipoic
- lipoic acid
- acid
- use according
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 3
- 208000000509 infertility Diseases 0.000 title claims 2
- 230000036512 infertility Effects 0.000 title claims 2
- 231100000535 infertility Toxicity 0.000 title claims 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims 9
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims 8
- 235000019152 folic acid Nutrition 0.000 claims 5
- 239000011724 folic acid Substances 0.000 claims 5
- 235000019136 lipoic acid Nutrition 0.000 claims 4
- 229960002663 thioctic acid Drugs 0.000 claims 4
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 claims 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims 2
- 229930003761 Vitamin B9 Natural products 0.000 claims 2
- 229940064302 folacin Drugs 0.000 claims 2
- 229960000304 folic acid Drugs 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 235000019159 vitamin B9 Nutrition 0.000 claims 2
- 239000011727 vitamin B9 Substances 0.000 claims 2
- AGBQKNBQESQNJD-ZETCQYMHSA-N (S)-lipoic acid Chemical compound OC(=O)CCCC[C@H]1CCSS1 AGBQKNBQESQNJD-ZETCQYMHSA-N 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 229960000367 inositol Drugs 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Claims (6)
1. Pripravak koji sadrži:
- vitamin B9 ili folnu kiselinu ili folacin, i
- mioinozitolom, i
- alfa lipoičnu kiselinu,
za uporabu u liječenju neplodnosti.
2. Pripravak za uporabu sukladno zahtjevu 1, pri čemu je alfa lipoična kiselina prisutna kao 50/50 racemična mješavina R-(+)-alfa lipoična kiselina/S-(-)-alfa lipoična kiselina.
3. Pripravak za uporabu sukladno zahtjevu 1 ili 2, pri čemu je alfa lipoična kiselina prisutna u mikrokapsuliranom ili prevučenom obliku.
4. Pripravak za uporabu sukladno bilo kojem od prethodnih zahtjeva, pri čemu se navedeni pripravak sastoji od:
- vitamina B9 ili folne kiseline ili folacina, poželjno pteroilmonoglutaminske kiseline;
- mioinozitoloma;
- alfa lipoične kiseline u obliku 50/50 racemične mješavine R-(+)-alfa lipoične kiseline/S-(-)- alfa lipoične ekscipijenata i tehnoloških aditiva.
5. Pripravak za uporabu sukladno bilo kojem od prethodnih zahtjeva, pri čemu je navedeni pripravak u čvrstom obliku radi oralne primjene, poželjno tabletama ili granulama za vrećice ili čvrstima kapsulama.
6. Pripravak za uporabu sukladno bilo kojem od prethodnih zahtjeva kao farmaceutski pripravak ili nadomjesni proizvod.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2010A002313A IT1403587B1 (it) | 2010-12-17 | 2010-12-17 | Composizione per il trattamento di disordini metabolici |
| EP11813358.6A EP2651251B1 (en) | 2010-12-17 | 2011-12-19 | Composition for the treatment of infertility |
| PCT/IB2011/003085 WO2012080831A1 (en) | 2010-12-17 | 2011-12-19 | Composition for the treatment of metabolic disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20160978T1 true HRP20160978T1 (hr) | 2016-10-07 |
Family
ID=43736968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20160978TT HRP20160978T1 (hr) | 2010-12-17 | 2016-08-01 | Pripravak za liječenje neplodnosti |
Country Status (12)
| Country | Link |
|---|---|
| EP (2) | EP3081097B8 (hr) |
| BR (1) | BR112013015048A2 (hr) |
| DK (2) | DK2651251T3 (hr) |
| ES (2) | ES2763437T3 (hr) |
| HR (1) | HRP20160978T1 (hr) |
| HU (2) | HUE029493T2 (hr) |
| IT (1) | IT1403587B1 (hr) |
| PL (2) | PL2651251T3 (hr) |
| PT (2) | PT3081097T (hr) |
| RS (1) | RS55057B1 (hr) |
| RU (1) | RU2586742C2 (hr) |
| WO (1) | WO2012080831A1 (hr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011205730C1 (en) | 2010-01-14 | 2014-10-09 | Nuvo Research Inc. | Solid-forming local anesthetic formulations for pain control |
| ITMI20130349A1 (it) * | 2013-03-07 | 2014-09-08 | Laborest Italia S P A | Composizione per uso nel trattamento della sindrome dell ovaio policistico |
| ITUA20163025A1 (it) | 2016-04-29 | 2017-10-29 | Sochim Int S P A | Composizione per il trattamento della sindrome dell’ovaio policistico |
| US11898184B2 (en) | 2017-09-07 | 2024-02-13 | Sweet Sense Inc. | Low glycemic sugar composition |
| WO2020112699A1 (en) | 2018-11-26 | 2020-06-04 | The Procter & Gamble Company | Solid pharmaceutical preparation containing lipoic acid and use thereof |
| RU2757220C1 (ru) * | 2020-06-03 | 2021-10-12 | Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" | Фармацевтическая композиция для профилактики и лечения синдрома поликистозных яичников |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2152787C2 (ru) * | 1994-06-02 | 2000-07-20 | Дан Рига | Лекарство против стресса, против снижения уровня активности и против старения и способ его получения |
| US20020155163A1 (en) * | 1999-12-27 | 2002-10-24 | Samuel D. Benjamin | Integrated multi-vitamin and mineral combination |
| US20040043013A1 (en) * | 2000-12-28 | 2004-03-04 | Mccleary Edward Larry | Metabolic uncoupling therapy |
| US20070065456A1 (en) * | 2005-09-20 | 2007-03-22 | Woods Cindy J | Nutritional supplements |
-
2010
- 2010-12-17 IT ITMI2010A002313A patent/IT1403587B1/it active
-
2011
- 2011-12-19 RU RU2013130308/15A patent/RU2586742C2/ru not_active IP Right Cessation
- 2011-12-19 EP EP16171147.8A patent/EP3081097B8/en active Active
- 2011-12-19 WO PCT/IB2011/003085 patent/WO2012080831A1/en active Application Filing
- 2011-12-19 DK DK11813358.6T patent/DK2651251T3/en active
- 2011-12-19 ES ES16171147T patent/ES2763437T3/es active Active
- 2011-12-19 HU HUE11813358A patent/HUE029493T2/en unknown
- 2011-12-19 EP EP11813358.6A patent/EP2651251B1/en active Active
- 2011-12-19 PT PT161711478T patent/PT3081097T/pt unknown
- 2011-12-19 ES ES11813358.6T patent/ES2586930T3/es active Active
- 2011-12-19 PL PL11813358T patent/PL2651251T3/pl unknown
- 2011-12-19 HU HUE16171147A patent/HUE047320T2/hu unknown
- 2011-12-19 PL PL16171147T patent/PL3081097T3/pl unknown
- 2011-12-19 BR BR112013015048A patent/BR112013015048A2/pt not_active IP Right Cessation
- 2011-12-19 PT PT118133586T patent/PT2651251T/pt unknown
- 2011-12-19 RS RS20160651A patent/RS55057B1/sr unknown
- 2011-12-19 DK DK16171147.8T patent/DK3081097T3/da active
-
2016
- 2016-08-01 HR HRP20160978TT patent/HRP20160978T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2586930T3 (es) | 2016-10-19 |
| EP3081097B1 (en) | 2019-12-04 |
| RU2013130308A (ru) | 2015-01-27 |
| DK3081097T3 (da) | 2020-01-20 |
| ITMI20102313A1 (it) | 2012-06-18 |
| HUE029493T2 (en) | 2017-02-28 |
| PT3081097T (pt) | 2020-01-14 |
| EP3081097A1 (en) | 2016-10-19 |
| EP2651251A1 (en) | 2013-10-23 |
| WO2012080831A1 (en) | 2012-06-21 |
| ES2763437T3 (es) | 2020-05-28 |
| IT1403587B1 (it) | 2013-10-31 |
| PL2651251T3 (pl) | 2017-06-30 |
| BR112013015048A2 (pt) | 2016-07-19 |
| PT2651251T (pt) | 2016-08-19 |
| EP3081097B8 (en) | 2020-01-08 |
| EP2651251B1 (en) | 2016-06-01 |
| DK2651251T3 (en) | 2016-09-05 |
| HUE047320T2 (hu) | 2020-04-28 |
| RU2586742C2 (ru) | 2016-06-10 |
| RS55057B1 (sr) | 2016-12-30 |
| PL3081097T3 (pl) | 2020-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20160978T1 (hr) | Pripravak za liječenje neplodnosti | |
| RS54559B1 (en) | APIKSABAN FORMULATIONS | |
| MD4490C1 (ro) | Noi compuşi de indolizină, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin | |
| JP2012031131A5 (hr) | ||
| IN2015DN01662A (hr) | ||
| PH12016501310A1 (en) | Pharmaceutical compositions comprising azd9291 | |
| JP2012031147A5 (hr) | ||
| IL217052A0 (en) | Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them | |
| HRP20180196T1 (hr) | Diketoni i hidroksiketoni kao aktivatori puta signalizacije katenina | |
| IN2014DN01992A (hr) | ||
| NZ709648A (en) | Crystalline forms of 3-(imidazo[1,2-b] pyridazin-3-ylethynyl)-4-methyl-n-(4-[(4-methylpiperazin-1-yl) methyl]-3-(trifluoromethyl)phenyl)benzamide and its mono hydrochloride salt | |
| MA34055B1 (fr) | Chlorhydrate d'agomelatine hydrate et sa preparation | |
| GEP20166488B (en) | Co-crystals and salts of ccr3-inhibitors | |
| EA201492091A1 (ru) | Фармацевтические композиции для местного применения, содержащие тербинафид и мочевину | |
| ZA201500362B (en) | Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient | |
| HRP20171649T1 (hr) | 4-supstituirani spojevi 3-fenilsulfanilmetilbiciklo[3.1.0]heksana kao antagonisti mglur 2/3 | |
| EA201500376A1 (ru) | Композиция для ухода за полостью рта | |
| MX2012008413A (es) | Composicion novedosa de retigabina. | |
| RU2015140499A (ru) | Композиция для применения в лечении синдрома поликистоза яичников | |
| MX360047B (es) | Unidad sólida con alto contenido en fexofenadina y su procedimiento de preparación. | |
| HRP20180537T1 (hr) | Uporaba agomelatina za pripravu lijekova za liječenje opsesivno-kompulzivnog poremećaja (ocd) | |
| EP2871187A4 (en) | NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT | |
| MX2013013079A (es) | Composiciones que comprenden un agente antibacterial y tazobactam. | |
| WO2014006635A3 (en) | Solid oral compositions of silodosin | |
| MX2013012773A (es) | Sustancias farmacologicas, composiciones farmaceuticas y metodos para la preparacion de las mismas. |